Charles H. Abdalian
Geen lopende functies
Loopbaan van Charles H. Abdalian
Eerdere bekende functies van Charles H. Abdalian
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BG MEDICINE, INC. | Financieel Directeur/CFO | 03-11-2013 | 03-11-2013 |
Investor Relations Contact | 03-11-2013 | 03-11-2013 | |
Public Communications Contact | 03-11-2013 | 03-11-2013 | |
Treasurer | 03-11-2013 | 03-11-2013 | |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Financieel Directeur/CFO | 01-03-2004 | 03-05-2011 |
Pelias Technologies, Inc.
Pelias Technologies, Inc. Pharmaceuticals: GenericHealth Technology Pelias Technologies, Inc. develops long term sustained release drug encapsulation and delivery systems. The company was founded in 1997 and is headquartered in Cambridge, MA. | President | 01-10-2001 | 01-12-2002 |
EMISPHERE TECHNOLOGIES, INC. | Financieel Directeur/CFO | 01-03-1999 | 01-07-2001 |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Tafkak, Inc. provides genome sequencing and analysis solutions. It offers tools and solutions to researchers, drug developers and clinicians determine the genetic basis of human disease and drug response. The firm provides knomeCLINIC a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating and comparing sequence data. It also offers knomeVARIANTS, a discovery-supportive interpretation tool, which helps researchers to find causal variants and genes. The company was founded by Jorge Conde and George M. Church in 2007 and is headquartered in Waltham, MA. | Financieel Directeur/CFO | 01-01-2012 | - |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Financieel Directeur/CFO | 10-08-2009 | 13-12-2010 |
Public Communications Contact | 17-05-2010 | - | |
Coopers & Lybrand LLP | Corporate Officer/Principal | - | - |
Opleiding van Charles H. Abdalian
University of Pennsylvania | Masters Business Admin |
Norwich University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 10 |
Operationeel
Director of Finance/CFO | 5 |
Public Communications Contact | 2 |
Masters Business Admin | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BG MEDICINE, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
Pelias Technologies, Inc.
Pelias Technologies, Inc. Pharmaceuticals: GenericHealth Technology Pelias Technologies, Inc. develops long term sustained release drug encapsulation and delivery systems. The company was founded in 1997 and is headquartered in Cambridge, MA. | Health Technology |
Emisphere Technologies, Inc.
Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
Coopers & Lybrand LLP | Commercial Services |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Tafkak, Inc. provides genome sequencing and analysis solutions. It offers tools and solutions to researchers, drug developers and clinicians determine the genetic basis of human disease and drug response. The firm provides knomeCLINIC a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating and comparing sequence data. It also offers knomeVARIANTS, a discovery-supportive interpretation tool, which helps researchers to find causal variants and genes. The company was founded by Jorge Conde and George M. Church in 2007 and is headquartered in Waltham, MA. | Commercial Services |
- Beurs
- Insiders
- Charles H. Abdalian
- Ervaring